Cargando…
MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1
Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is responsible for metabolism of an endogenous inhibitor of nitric oxide synthase (NOS), asymmetric dimethylarginine (ADMA), which plays a key role in modulating angiogenesis. In addition to angiogenesis, tumours can establish a vascular network by f...
Autores principales: | Hulin, Julie-Ann, Tommasi, Sara, Elliot, David, Hu, Dong Gui, Lewis, Benjamin C., Mangoni, Arduino A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656623/ https://www.ncbi.nlm.nih.gov/pubmed/29070803 http://dx.doi.org/10.1038/s41598-017-14454-1 |
Ejemplares similares
-
Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer
por: Hulin, Julie-Ann, et al.
Publicado: (2020) -
Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
por: Murphy, Rhys B., et al.
Publicado: (2016) -
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: Tommasi, S., et al.
Publicado: (2017) -
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase
por: Ragavan, Vinitha N., et al.
Publicado: (2023) -
Divergent Dimethylarginine Dimethylaminohydrolase Isoenzyme Expression in the Central Nervous System
por: Kozlova, Alena A., et al.
Publicado: (2021)